FDA Inspection
Novartis Pharmaceuticals CorporationNovartis Pharmaceuticals Corporation – FDA Inspection, Feb 25, 2011
Record Details
This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on February 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 25, 2011
- Product Type
- Drugs
View Company Profile
ID · 90cba958-0b54-4e35-aef1-8449422becfd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 715718
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.56(b)Investigator non-compliance
- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Novartis Pharmaceuticals Corporation
30| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2026 | Not classified | New Jersey District Office | |
| June 25, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 3, 2025 | Not classified | New Jersey District Office | |
| November 19, 2024 | Not classified | New Jersey District Office | |
| August 29, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Novartis Pharmaceuticals Corporation
- FDA Inspection 1328008 - 2026-06-24
- FDA Inspection 1276202 - 2025-06-25
- FDA Inspection 1263198 - 2025-03-03
- FDA Inspection 1257911 - 2024-11-19
- FDA Inspection 1248433 - 2024-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.